35Q-21048-98651
4 vaccinations
2 coded responses
34 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 615 / IL
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
- 2021-03-09
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-01
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Itching · Headache, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-05-01
- 2021-05-06
- 2021-05-13
- 2021-07-01
- 2021-09-30
-
2021-12-12
Dose 3 — Pfizer-BioNTech
- 2022-04-01
- 2022-06-12
-
2022-09-25
Dose 4 — Pfizer-BioNTech
-
2022-09-25
Health check-in — day 0, dose 4Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-23
-
2022-10-30
Survey response — day 35, dose 4MedDRA: COVID-19, Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID-19 symptoms and positive test. Sore throat, coughing, fatigue, congestion and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Survey response — day 42, dose 4MedDRA: Asthenia, COVID-19, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Positive for COVID-19 Headache, fatigue, weaknessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-07
-
2022-11-08
Call successfulParticipant prefers to complete VAERS report online
- 2022-12-25
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-12-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-06 | Successful 2022-11-08 |
Participant prefers to complete VAERS report online |
Free text
Release 12 — day 35, dose 4
Symptoms: COVID-19 symptoms and positive test. Sore throat, coughing, fatigue, congestion and runny nose
Release 12 — day 42, dose 4
Symptoms: Positive for COVID-19 Headache, fatigue, weakness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release